Paul Arora
Canada
Research Article
The Relationship between Metabolic Syndrome and Markers of Cardiometabolic Disease among Canadian Adults
Author(s): Darren R. Brenner, Paul Arora, Bibiana Garcia-Bailo, Howard Morrison, Ahmed El-Sohemy, Mohamed Karmali and Alaa BadawiDarren R. Brenner, Paul Arora, Bibiana Garcia-Bailo, Howard Morrison, Ahmed El-Sohemy, Mohamed Karmali and Alaa Badawi
Background: The metabolic syndrome (MetS) is a well-established risk factor for cardiometabolic disease. However, the association between MetS, and its components, with the metabolic phenotypes and inflammatory markers that are risk factor for cardiometabolic disease has not been explored in the general population. The present study examines this association among Canadian adults and explores the changes in the profile of a number of metabolic and inflammatory markers associated with cardiometabolic disease at various MetS stages.
Methods: Serum levels of apolipoprotein A1 and B (Apo-A1, -B), total:HDL-cholesterol (HDL-C) ratio, C-reactive protein (CRP), fibrinogen, glycosylated haemoglobin (HbA1c) and homocysteine were determined in 1,818 non-diabetic adults (16-79 years of age) from the Canadian Health Measures Survey (CH.. View More»
